Press Releases

City of Boston

Councilors Flynn and Murphy introduced a resolution in support of establishing a committee to maintain and attract young adults to the City of Boston.

GlobeNewswire, Inc.

Following alignment discussions with FDA, BLA completion for HR BCG-unresponsive NMIBC is expected fourth quarter 2026 PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC...

U.S. Customs and Border Protection

PHILADELPHIA – U.S. Customs and Border Protection officers seized a half gallon of gamma-butyrolactone, known on the street and at raves as “Blue Nitro” or liquid ecstasy, in Philadelphia on April 25. CBP officers seized 8 bottles of GBL, a...

GlobeNewswire, Inc.

BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the appointment of Nelson Azoulay as Chief Business...

EIN Presswire

The global TAVR market is growing rapidly, driven by aging populations, minimally invasive procedures, expanding indications, and rising patient awareness.

EIN Presswire

From a small gathering to a thriving community of 3,000+ members, CFOLC marks two decades of impact, collaboration, and leadership.

GlobeNewswire, Inc.

First Quarter 2026 Revenue Totaled $12.3 Million First Quarter 2026 Net Income Attributable to Common Stockholders Totaled $5.8 Million, Funds from Operations Totaled $9.7 Million, and Adjusted Funds from Operations Totaled $10.1 Million...

GlobeNewswire, Inc.

First Quarter Financial Highlights: Total revenues decreased $12.5 million year over year to $410.5 million.

EIN Presswire

John Ocampo’s Legacy Continues with Donations to Support Industry Innovation, Academic Excellence, and the Next Generation of Semiconductor Pioneers SANTA CLARA, CA, UNITED STATES, May 19, 2026 /⁨EINPresswire.com⁩/ -- Susan Ocampo, co-founder of...

GlobeNewswire, Inc.

Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance Three presentations at upcoming TIDES USA annual meeting to feature new data for ECO Synthesis manufacturing platform capabilities REDWOOD...

GlobeNewswire, Inc.

BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) has earned two 2026 Responsible Care® Awards from the American Chemistry Council (ACC): the Waste & Water Stewardship Award and Facility Safety Award.

GlobeNewswire, Inc.

BOSTON HEIGHTS, Ohio, May 07, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, reported first...

GlobeNewswire, Inc.

WESTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Students and working adults across Massachusetts will soon have expanded access to career training in healthcare and IT through a new partnership between MedCerts, a nationally recognized leader in...

City of Boston

Mayor Michelle Wu and the Boston Athletic Association (B.A.A.) today announced the recipients of the Fastest Bostonians Awards, given to four Boston residents with the quickest finish times at the 130th Boston Marathon presented by Bank of...

GlobeNewswire, Inc.

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026 Five additional Phase 3 studies of azetukalner continue to enroll in epilepsy and depression indications with Phase 3...

GlobeNewswire, Inc.

Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling from HEADLINE trial supports ABS-201's targeted...

GlobeNewswire, Inc.

Advancing next-generation γδ T cell engager platform with initial animal data expected in 2026 Reported glioblastoma (GBM) data showing ~97% improvement in progression-free survival vs. standard-of-care; updated median overall survival (mOS) data...

GlobeNewswire, Inc.

TX45 APEX Phase 2 patient enrollment in PH-HFpEF is nearing completion with topline results anticipated in late Q4 2026 or early Q1 2027 TX2100 advanced into Phase 1a healthy volunteer clinical trial in February 2026 as a potential treatment for...

GlobeNewswire, Inc.

Company announcement – No. 14 / 2026 Zealand Pharma Announces Financial Results for the First Three Months of 2026 A defining start to 2026, marked by pivotal progress for leading obesity assets, petrelintide and survodutide, and strong momentum...

GlobeNewswire, Inc.

LOWELL, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced its financial results for its fiscal second quarter ended April 3,...